NasdaqGS:ILMNLife Sciences
Illumina (ILMN) Faces A German Recall Order, Is The Stock Fully Priced?
A German court ruling against Illumina (ILMN) over alleged patent infringement by its DNA sequencing systems has forced an injunction and recall in Germany, placing legal, operational, and reputational risks in sharper focus for investors.
See our latest analysis for Illumina.
The legal setback in Germany comes after a strong run in Illumina’s stock, with a 30-day share price return of 18.90% and a 90-day share price return of 47.53%. However, the 1-year total shareholder return of 88.70%...